Finance

Lists
Why is RVV up 20,00%?
Dive Deeper
RVV:CNSX
Revive Therapeutics Ltd
CAD 0,030
+20,00%
(+0,0050) 1D
13 Okt., 16:00:00 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for RVV...
Open
CAD 0,03
High
CAD 0,03
Low
CAD 0,03
Mkt. cap
10,49 m
Avg. vol.
161,87 k
Volume
6,66 k
52-wk high
CAD 0,08
52-wk low
CAD 0,00
EPS
-CAD 0,03
Open
CAD 0,03
High
CAD 0,03
Low
CAD 0,03
Mkt. cap
10,49 m
Avg. vol.
161,87 k
Volume
6,66 k
52-wk high
CAD 0,08
52-wk low
CAD 0,00
EPS
-CAD 0,03
News stories
From web sources and news partners
About Revive Therapeutics Ltd
CEO-
Employees-
Founded2012
HeadquartersToronto, Ontario, Kanada
SectorPharmaceutical industry
Websiterevivethera.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
336,32 k
200,14 k
283,25 k
242,05 k
Operating expense
336,39 k
220,13 k
283,30 k
463,87 k
Total operating expenses
336,39 k
220,13 k
283,30 k
463,87 k
Operating income
-336,39 k
-220,13 k
-283,30 k
-463,87 k
Other non operating income
73,85 k
-
-
-
EBT including unusual items
-9,60 m
-281,75 k
-238,72 k
-506,50 k
EBT excluding unusual items
-143,94 k
-281,75 k
-234,70 k
-506,50 k
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9,60 m
-281,75 k
-238,72 k
-506,50 k
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
277,00
-
-
Interest expense
-
-
-
-
Net interest expenses
-
277,00
-
-
Depreciation and amortization charges
62,00
46,00
48,00
47,00
EBITDA
-336,32 k
-220,08 k
-283,25 k
-463,82 k
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme